DCF — NORTH ALABAMA MEDICAL CENTER
Enterprise Value: $-38.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-38.9M
Enterprise Value
$-19.1M
PV of Cash Flows
$-19.9M
PV of Terminal Value
$-32.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $267.2M | $2.7M | 1.0% | $-8.6M | $-7.8M |
| Year 2 | $275.3M | $5.6M | 2.0% | $-6.1M | $-5.0M |
| Year 3 | $283.5M | $8.6M | 3.0% | $-3.8M | $-2.9M |
| Year 4 | $292.0M | $10.3M | 4.0% | $-2.8M | $-1.9M |
| Year 5 | $300.8M | $11.3M | 4.0% | $-2.3M | $-1.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-38.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$259.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.005232028195019457
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5